Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties. (Q41104653)
Jump to navigation
Jump to search
scientific article published on June 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties. |
scientific article published on June 1997 |
Statements
Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties (English)
Hornick JL
Khawli LA
Hu P
Lynch M
Anderson PM